vimarsana.com

Page 10 - ஒருங்கிணைந்த தடுப்பூசி சிக்கலான News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HLL Biotech may soon find suitor to produce vaccine - The Hindu BusinessLine

DMK asks Centre to manufacture vaccine in Tamil Nadu

Expedite work at Chengalpattu vaccine facility, Anbumani tells Harsh Vardhan

Expedite work at Chengalpattu vaccine facility, Anbumani tells Harsh Vardhan Updated: Updated: COVID-19 vaccines can be produced from the facility, says PMK leader Share Article COVID-19 vaccines can be produced from the facility, says PMK leader PMK leader and Rajya Sabha member Anbumani Ramadoss has urged Union Health Minister Harsh Vardhan to immediately make the Integrated Vaccine Complex at Chengalpattu functional so that COVID-19 vaccines can be produced from the facility. In a letter, Dr. Ramadoss said he had already written to the Minister in October 2019 regarding expediting the completion works of the complex. “The works at this complex are nearly complete. It is possible to complete the remaining work and start producing vaccines as per WHO pre-qualification norm which is the international standard,” he said.

TN-based HLL Biotech facilities not used for vaccine manufacturing

TN-based HLL Biotech facilities not used for vaccine manufacturing ​ By IANS | ​ 4 Views TN-based HLL Biotech facilities not used for vaccine manufacturing. Image Source: IANS News Chennai, May 12 : HLL Biotech at Chengalpet in Tamil Nadu, a sprawling 100-acre campus located 55 km from Chennai, is equipped with all modern facilities and has state-of-the-art technology to manufacture vaccines but was not used during the first wave of the Covid-19 pandemic. There were not many takers to use the Public Sector Undertaking facility even after it floated a tender for its Integrated Vaccine Complex (IVC) to manufacture vaccines. HLL Biotech has an annual capacity of 585 million vaccine doses and was intended to make vaccines under the Universal Immunisation Programme (UIP) of the Indian Government. The company was formed to produce an uninterrupted supply of vaccines under the UIP. It has the state-of-the-art multi-bacterial and multi-viral facilities to meet any epidemic or p

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.